#BEGIN_DRUGCARD DB04517

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
42121

# Chemical_Formula:
C20H24N2O8

# Chemical_IUPAC_Name:
3-[(2R)-2-{[3-(2-carboxyethyl)-4-(carboxymethyl)-2H-pyrrol-5-yl]methyl}-4-(carboxymethyl)-5-methyl-2H-pyrrol-3-yl]propanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Dipyrromethane Cofactor

# HET_ID:
DPM

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C20H24N2O8/c1-10-13(6-19(27)28)12(3-5-18(25)26)16(22-10)8-15-14(7-20(29)30)11(9-21-15)2-4-17(23)24/h16H,2-9H2,1H3,(H,23,24)(H,25,26)(H,27,28)(H,29,30)/t16-/m1/s1

# InChI_Key:
InChIKey=PIVMSLFNTMAVDI-MRXNPFEDSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4517

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
420.4132

# Molecular_Weight_Mono:
420.153265754

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1GTK

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.18

# Predicted_LogS:
-4

# Predicted_Water_Solubility:
4.07e-02 g/l

# Primary_Accession_No:
DB04517

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936996

# PubChem_Substance_ID:
46504454

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01256

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC1=N[C@H](CC2=NCC(CCC(O)=O)=C2CC(O)=O)C(CCC(O)=O)=C1CC(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:25 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X04242

# Drug_Target_1_GenBank_ID_Protein:
41664

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
hemC

# Drug_Target_1_Gene_Sequence:
>942 bp
ATGTTAGACAATGTTTTAAGAATTGCCACACGCCAAAGCCCACTTGCACTCTGGCAGGCA
CACTATGTCAAAGACAAGTTGATGGCGAGCCATCCGGGCCTGGTCGTTGAACTGGTACCG
ATGGTGACGCGCGGCGATGTGATTCTTGATACGCCGCTGGCGAAAGTAGGCGGAAAAGGC
TTATTTGTAAAAGAGCTGGAAGTCGCGCTCCTCGAAAATCGCGCCGATATCGCCGTACAC
TCAATGAAAGATGTGCCGGTTGAATTCCCGCAAGGTCTGGGACTGGTCACTATTTGTGAG
CGTGAAGATCCTCGCGATGCCTTTGTGTCCAATAACTATGACAGTCTGGATGCGTTACCG
GCAGGCAGTATCGTCGGGACGTCCAGTTTACGTCGCCAGTGCCAACTGGCTGAACGCCGT
CCGGATCTGATTATCCGCTCCCTGCGCGGCAACGTCGGCACTCGCCTGAGCAAACTGGAT
AACGGCGAATACGATGCCATCATTCTTGCCGTAGCCGGACTAAAACGTTTAGGTCTGGAG
TCACGTATTCGCGCCGCGTTGCCACCCGAGATTTCTCTTCCGGCGGTAGGACAAGGTGCG
GTGGGTATTGAATGCCGCCTTGATGATTCACGCACTCGCGAGCTGCTTGCCGCGCTGAAT
CACCACGAAACTGCACTGCGCGTTACCGCAGAACGCGCCATGAATACCCGTCTCGAAGGC
GCATGTCAGGTGCCAATTGGTAGCTACGCCGAGCTTATTGATGGCGAAATCTGGCTGCGT
GGGCTGGTCGGCGCGCCGGACGGTTCGCAGATTATTCGCGGTGAACGCCGCGGTGCGCCG
CAAGATGCCGAACAAATGGGGATTTCGCTGGCAGAAGAGCTACTGAATAACGGCGCGCGC
GAGATCCTCGCTGAAGTCTATAACGGAGACGCCCCGGCATGA

# Drug_Target_1_General_Function:
Coenzyme transport and metabolism

# Drug_Target_1_General_References:
1379743	Daniels DL, Plunkett G 3rd, Burland V, Blattner FR: Analysis of the Escherichia coli genome: DNA sequence of the region from 84.5 to 86.5 minutes. Science. 1992 Aug 7;257(5071):771-8.
1522882	Louie GV, Brownlie PD, Lambert R, Cooper JB, Blundell TL, Wood SP, Warren MJ, Woodcock SC, Jordan PM: Structure of porphobilinogen deaminase reveals a flexible multidomain polymerase with a single catalytic site. Nature. 1992 Sep 3;359(6390):33-9.
1747120	Jordan PM, Woodcock SC: Mutagenesis of arginine residues in the catalytic cleft of Escherichia coli porphobilinogen deaminase that affects dipyrromethane cofactor assembly and tetrapyrrole chain initiation and elongation. Biochem J. 1991 Dec 1;280 ( Pt 2):445-9.
2025226	Lander M, Pitt AR, Alefounder PR, Bardy D, Abell C, Battersby AR: Studies on the mechanism of hydroxymethylbilane synthase concerning the role of arginine residues in substrate binding. Biochem J. 1991 Apr 15;275 ( Pt 2):447-52.
2122889	Hadener A, Alefounder PR, Hart GJ, Abell C, Battersby AR: Investigation of putative active-site lysine residues in hydroxymethylbilane synthase. Preparation and characterization of mutants in which (a) Lys-55, (b) Lys-59 and (c) both Lys-55 and Lys-59 have been replaced by glutamine. Biochem J. 1990 Oct 15;271(2):487-91.
2510713	Miller AD, Packman LC, Hart GJ, Alefounder PR, Abell C, Battersby AR: Evidence that pyridoxal phosphate modification of lysine residues (Lys-55 and Lys-59) causes inactivation of hydroxymethylbilane synthase (porphobilinogen deaminase). Biochem J. 1989 Aug 15;262(1):119-24.
3052434	Jordan PM, Thomas SD, Warren MJ: Purification, crystallization and properties of porphobilinogen deaminase from a recombinant strain of Escherichia coli K12. Biochem J. 1988 Sep 1;254(2):427-35.
3054815	Alefounder PR, Abell C, Battersby AR: The sequence of hemC, hemD and two additional E. coli genes. Nucleic Acids Res. 1988 Oct 25;16(20):9871.
3196304	Miller AD, Hart GJ, Packman LC, Battersby AR: Evidence that the pyrromethane cofactor of hydroxymethylbilane synthase (porphobilinogen deaminase) is bound to the protein through the sulphur atom of cysteine-242. Biochem J. 1988 Sep 15;254(3):915-8.
3529035	Thomas SD, Jordan PM: Nucleotide sequence of the hemC locus encoding porphobilinogen deaminase of Escherichia coli K12. Nucleic Acids Res. 1986 Aug 11;14(15):6215-26.
8874804	Trotot P, Sismeiro O, Vivares C, Glaser P, Bresson-Roy A, Danchin A: Comparative analysis of the cya locus in enterobacteria and related gram-negative facultative anaerobes. Biochimie. 1996;78(4):277-87.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3200

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
33852

# Drug_Target_1_Name:
Porphobilinogen deaminase

# Drug_Target_1_Number_of_Residues:
313

# Drug_Target_1_PDB_ID:
2YPN

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01379	Porphobil_deam
PF03900	Porphobil_deamC

# Drug_Target_1_Protein_Sequence:
>Porphobilinogen deaminase
MLDNVLRIATRQSPLALWQAHYVKDKLMASHPGLVVELVPMVTRGDVILDTPLAKVGGKG
LFVKELEVALLENRADIAVHSMKDVPVEFPQGLGLVTICEREDPRDAFVSNNYDSLDALP
AGSIVGTSSLRRQCQLAERRPDLIIRSLRGNVGTRLSKLDNGEYDAIILAVAGLKRLGLE
SRIRAALPPEISLPAVGQGAVGIECRLDDSRTRELLAALNHHETALRVTAERAMNTRLEG
GCQVPIGSYAELIDGEIWLRALVGAPDGSQIIRGERRGAPQDAEQMGISLAEELLNNGAR
EILAEVYNGDAPA

# Drug_Target_1_Reaction:
4 porphobilinogen + H2O = hydroxymethylbilane + 4 NH3

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Tetrapolymerization of the monopyrrole PBG into the hydroxymethylbilane pre-uroporphyrinogen in several discrete steps

# Drug_Target_1_SwissProt_ID:
P06983

# Drug_Target_1_SwissProt_Name:
HEM3_ECOLI

# Drug_Target_1_Synonyms:
EC 2.5.1.61
HMBS
Hydroxymethylbilane synthase
PBG
Pre-uroporphyrinogen synthase

# Drug_Target_1_Theoretical_pI:
5.12

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04517
